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Purpose: Moyamoya disease (MMD) occurs predominantly in Korean and Japa-
nese women. The aim of this study was to investigate clinical features and pregnancy 
outcomes in women with MMD. Materials and Methods: We conducted a retro-
spective chart review of women with MMD who visited our Department of Obstet-
rics and Gynecology between January 2005 and October 2013. For all study sub-
jects, clinical features, demographic characteristics, and perinatal outcomes were 
recorded. Results: We identified 28 pregnancies in 22 patients who had been diag-
nosed with MMD. The mean maternal age at delivery was 31.9±3.5 years old. The 
mean gestational age at delivery was 38.0±0.9 weeks. Among the 28 pregnancies, 25 
(92.5%) underwent cesarean section; 19 (76.0%) of them were performed under re-
gional anesthesia and six (24.0%) under general anesthesia. The mean newborn 
weight was 3233.7±348.2 g. The 5-minute Apgar score in 85% of the newborns was 
higher than 8, with no other apparent complications. During the puerperal period, 
transient ischemic attack symptom or seizure occurred in 4 cases, although patients 
recovered within a few days. Conclusion: For pregnant women with MMD, it is im-
portant to control blood pressure and prevent hyperventilation during the intrapartum 
period, and the best methods of delivery and anesthesia should be considered to 
avoid unfavorable sequelae. Additionally, a multidisciplinary approach (i.e., neuro-
surgery) is necessary to constantly manage underlying diseases.
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INTRODUCTION
Moyamoya disease (MMD) is characterized by angiographic findings of a bilateral 
steno-occlusion in the terminal internal carotid artery and an abnormal vascular 
formation of collateral vessels at the base of the brain.1 Clinical features of this dis-
ease vary depending on the age at onset: in children, symptoms include mainly ep-
ileptic seizures, motor paralysis, speech impediment, and intelligence decline due 
to transient ischemic attack (TIA) or cerebral infarction. In adults, headaches and 
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after pregnancy, history of pregnancy induced hypertension 
or preterm labor, gestational age at delivery, method of de-
livery and anesthesia, and the degree of disability or depen-
dence in the daily activities (modified Rankin Scale) after 
pregnancy, were investigated. Therapeutic abortion was 
performed in three cases because pregnancy was detected 
while subjects were under medication for MMD. These 
three cases were excluded from this study. 
Data are presented as the mean±standard deviation for 
continuous variables and as numbers and percentages for 
categorical variables. 
RESULTS
 
We identified 28 pregnancies in 22 patients who had been 
diagnosed with MMD. Most cases were diagnosed with 
MMD before childbirth. Only two cases were diagnosed 
with MMD during the postpartum period of a previous 
pregnancy. 
The mean maternal age at diagnosis was 26.8±4.5 years, 
and the initial symptoms at diagnosis were TIA in 12 cas-
es, hemorrhagic events in seven cases, and ischemic events 
in three cases. Twenty-six patients had already been diag-
nosed with MMD before their first pregnancy, whereas 2 
patients were diagnosed postpartum. The mean maternal 
age at delivery was 31.9±3.5 years. The rates of primipari-
ty (50%) and multiparity (50%) in women with MMD were 
similar. The mean gestational age at delivery was 38±0.9 
weeks. Of the 28 pregnancies, 25 (92.5%) underwent ce-
sarean section; 19 (76.0%) of them were performed under 
regional anesthesia, including combined epidural anesthe-
sia, and six (24.0%) under general anesthesia. The mean 
newborn weight was 3233.7±348.2 g, and Apgar scores at 
5 minutes for all neonates were above 6. Five-minute Ap-
gar scores in 85% of all neonates were above 8. Most new-
borns were in good condition, did not present any neonatal 
complications, and were discharged in a normal state (Ta-
ble 1). 
In this study, there was one case of preterm delivery due 
to premature rupture of membranes. While there were no 
cases of hypertensive events during pregnancy, three preg-
nant women had a history of pregnancy-induced hyperten-
sion. During pregnancy and puerperium, five out of 27 cases 
showed neurologic symptoms, which resolved spontaneous-
ly within a few days without any medication or procedure 
in four of the 5 patients (Table 2). Among the remaining 22 
consciousness impairments due to cerebral hemorrhage or 
cerebral ischemia are the major symptoms.2 
The frequency of MMD varies across different world re-
gions.3 Nonetheless, the clinical background of MMD in 
South Korea and in Japan is quite similar.4 The age distribu-
tion patterns of MMD in Korean patients show two peaks 
that are nearly identical to those seen in Japanese patients. 
Notwithstanding, the incidence of adult MMD in South 
Korea is reportedly 20% higher than that in Japan. A recent 
study showed that the incidence and prevalence of MMD in 
Korea were 2.3/105 and 16.1/105 in 2011, respectively,5 al-
though these results are higher than those in other studies. 
There is no evidence that pregnancy or delivery can in-
crease the risk of intracranial hematoma or cerebrovascular 
ischemia in women diagnosed with MMD. Nevertheless, 
physical changes, that is, increased blood flow, increased co-
agulability tendency, and hyperventilation, during delivery 
or labor can exacerbate the clinical symptoms of MMD.6 
Provided that blood pressure and hypocapnia are well man-
aged, pregnancy outcomes have been shown to be good,7,8 
although there are several reports of patients who experi-
enced ischemic stroke postpartum even when delivery was 
carefully managed.9,10 However, since only a few pregnant 
women are diagnosed with MMD, no standard obstetrical 
management protocol has been developed. 
Hence, this study aimed to investigate the effects of MMD 
on pregnancy outcomes and to provide evidence for estab-
lishing management protocols through which to ensure saf-
er childbirth in women with MMD.
MATERIALS AND METHODS
We conducted a retrospective review of 28 pregnancies in 
22 patients diagnosed with MMD before, during, or after 
pregnancy between January 2005 and October 2013 at the 
Department of Obstetrics and Gynecology, Severance Hos-
pital, Yonsei University College of Medicine. The diagnosis 
of MMD was based on characteristic angiographic findings 
of bilateral occlusion of the terminal internal carotid arteries 
and the proximal middle and anterior cerebral arteries, ac-
companied by extensive formation of collateral vessels. The 
study protocol was approved by the Institutional Review 
Board of Severance Hospital. 
Maternal age at diagnosis of MMD and at delivery, as 
well as obstetrical history, clinical symptoms at diagnosis, 
initial treatment, clinical neurological symptoms before and 
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patients, six underwent a surgical procedure including en-
cephalo-duro-arterio-synangiosis (EDAS) or external ven-
tricular drainage (EVD) after being diagnosed with MMD. 
All patients, excluding one who died, delivered at full term. 
The final neurologic outcomes were good with a modified 
Rankin Scale score of 0 in all cases except for one.
DISCUSSION
During the first and second trimester in pregnancy, circulat-
ing blood volumes increase by 30‒60%. As the circulating 
blood volume increases and blood coagulation intensifies, 
pregnancy-induced hypertension occurs, causing blood-
brain barrier disruption and vasospasm, which in turn in-
duces neurological deterioration in pregnant women with 
MDD.11 Therefore, it is thought that preventing cerebral 
ischemia and cerebral hemorrhage during pregnancy is im-
portant in patients with MMD. Although only a few studies 
have reported the pregnancy outcomes associated with 
MMD, recent results indicate that pregnant women diag-
nosed with MMD before pregnancy exhibit a lower inci-
dence of cerebrovascular events than those diagnosed with 
MMD during pregnancy and puerperium. If a woman is di-
agnosed with MMD during pregnancy and does not receive 
appropriate management, the incidence of cerebrovascular 
events increases and the prognosis is not good. Reportedly, 
the prognosis of pregnant women was good when blood 
pressure was strictly controlled, especially when precautions 
against pregnancy-induced hypertension were exerted.12 In 
this study, there were five cases of neurologic symptoms 
during pregnancy, which were related to TIA symptoms or 
seizure. Four patients recovered within a few days without 
the need for medication or surgical procedure, and there 
Table 1. Clinical Characteristics and Pregnancy Outcomes 
among Study Subjects 
Value (n=28)
Patient characteristics
    Maternal age (yrs) 31.9±3.5
    Parity
        Primipara 14 (50)
        Multipara 14 (50)
    Hypertension 0 (0) 
    History of preeclampsia    2 (7.1)
    Period at diagnosis
        Antepartum 0 (0)
        Postpartum    2 (7.1)
        Before pregnancy    26 (92.9)
    Initial clinical symptom at diagnosis
        Transient ischemic attack    12 (54.5)
        Hemorrhage      7 (31.8)
        Ischemia      3 (13.6)
Pregnancy outcomes
    Pregnancy induced hypertension 0 (0)
    Preterm premature rupture of membranes    1 (3.6)
    Neurologic event during antepartum      5 (17.9)
    Gestational age at delivery (wks) 38.0±0.9
    Mode of delivery
        Cesarean section    25 (92.5)
        Vaginal delivery    2 (7.4)
    Anesthesia
        Regional    19 (76.0)
        General      6 (24.0)
Neonatal outcomes
    Birth weight (g) 3233.7±348.2
    Apgar score (1 min)
        ≤4    1 (3.7)
        ≥5    26 (96.3)
    Apgar score (5 min)
        ≤7      4 (14.8)
        ≥8    23 (85.2)
    NICU admission after birth      1 (3.44)
NICU, neonatal intensive care unit.
Vales are given as mean±standard deviation or n (%) unless otherwise 
specified.
Table 2. Summary of Clinical Data from 5 Patients with Neurologic Symptoms due to Moyamoya Disease
Patient 
no.
Initial clinical 
symptom at 
diagnosis
Age, 
yrs Parity
Neurologic 
symptom Onset time Treatment Delivery
Apgar 
score, 
1‒5 min
Weight, 
g
Outcome 
(mRS)
1 Transient 
  ischemic attack
34 1 Right side weakness Postpartum 1 month Conservative Cesarean 8‒9 3680 0
2 Hemorrhage 29 2 Headache Postpartum 8 months Conservative Cesarean   9‒10 2960 1
3 Ischemia 37 1 Seizure IUP at 38 wks Conservative Cesarean 6‒8 3360 0
4 Hemorrhage 29 0 Both hand numbness,      headache IUP at 13 wks Conservative Cesarean 6‒8 3480 0
  5* Hemorrhage 30 1 Headache, syncope IUP at 16 wks Emergency   EVD
EVD, external ventricular drainage; IUP, intrauterine pregnancy; mRS, modified Rankin Scale.
*The patient was hospitalized with loss of consciousness and died due to intraventricular hemorrhage at the 16th weeks of gestation.
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fect prognosis. However, in case of primipara, the process 
of vaginal delivery is slow and, if epidural block is not per-
formed successfully, proper symptom management could 
be challenging, and thus, scheduled cesarean section could 
be considered as a safer option. 
There are various reports on outcomes according to the 
different types of anesthesia in women with MMD under-
going cesarean section. Strict blood pressure control, pre-
vention of hyperventilation, and maintaining cerebral blood 
flow are important to avoid unfavorable sequelae. General 
anesthesia can induce hypertension during intubation or ex-
tubation and carries the risk of stomach content aspiration. 
Under local anesthesia, neurologic symptoms can be moni-
tored, although caution should be exerted against hypoten-
sion.16 
This study has a few limitations. First, most patients in 
this study had normal blood pressure, and delivery was 
conducted uneventfully. However, 3 patients had a history 
of pregnancy-induced hypertension, although, in those cas-
es, their first deliveries took place at other hospitals and de-
tails regarding their conditions and deliveries were not avail-
able. Therefore, data review of our study population could 
not be perfectly conducted. Second, although Fukushima, 
et al.15 reported no significant difference in maternal and 
neonatal outcomes of a surgical treatment [external carotid 
artery-internal carotid artery bypass (EC-IC bypass)] group 
and a non-treatment group, we did not compare treatment 
groups. In our study, none of the patients underwent an 
anastomosis procedure, such as EC-IC bypass, although 
there were four cases of EDAS and three cases of EVD. 
Nevertheless, we assumed that comparisons between the 
groups would not be relevant since there were no cases 
with poor outcomes. Despite these limitations, this is the 
first study to investigate pregnancy outcomes in women 
with MMD at a single institute that treats mostly patients in 
Korea, which has high incidence of MMD. 
In conclusion, favorable maternal and perinatal outcomes 
can be achieved through proper management of pregnant 
women diagnosed with MMD. Therein, it is important to 
maintain normal blood pressure and prevent ventilatory dis-
turbance during delivery. When selecting delivery or anes-
thesia methods, risk factors associated with cerebrovascular 
events should be examined, as both the cesarean section 
and vaginal delivery have advantages and disadvantages. 
Furthermore, interdisciplinary collaboration with a neuro-
surgeon is essential for managing pregnant women diag-
nosed with MMD to avoid critical complications. 
were no further complications. However, one patient died 
before delivery due to intraventricular hemorrhage at 16th 
weeks of gestation. 
Liu, et al.13 reported that four cases of intracranial hemor-
rhage occurred out of a total of 144 cases of pregnancies 
among women with hemorrhagic MMD. Three patients 
had hemorrhages in the third trimester and one in the puer-
perium. Also, the hemorrhage rate during pregnancy was 
not significantly higher than that during the non-pregnancy 
period. It is not clear why intracranial hemorrhage develops 
during pregnancy in patients with MMD. The rupture of an 
aneurysm in the circle of Willis or rupture of fragile collat-
eral vessels was found to be the cause of bleeding in wom-
en who were not pregnant.14 However, Liu, et al.13 reported 
that three out of 4 patients were complicated by intracranial 
hemorrhages in the third trimester without any aneurysm 
verified by cerebral angiogram. Thus, intracranial hemor-
rhages in pregnant women with MMD might be related to 
gestational age. It is, therefore, assumed that increased 
blood volume, vascular resistance, and hormonal change 
might play a role in the pathogenesis of intracranial hemor-
rhage during the third trimester or early postpartum. Thus, 
careful management of blood pressure and hemodynamic 
parameters may be necessary during this period. 
Several studies have shown that cesarean section is the 
preferred mode of delivery in women with MMD and should 
be performed earlier before the estimated date of delivery. 
Vaginal delivery can induce hypertension, as well as hyper-
ventilation, during the second stage of labor, causing intracra-
nial hemorrhage or cerebral ischemia. Therefore, cesarean 
section is recommended to prevent this problem. However, 
cesarean section is associated with rapid circulatory chang-
es due to blood loss perioperatively and is not an uncondi-
tionally safe option. Vaginal delivery can be performed us-
ing epidural or spinal anesthesia depending on the case and 
it is not contraindicated. Fukushima, et al.15 reported vagi-
nal delivery was performed uneventfully in two out of 22 
pregnancy cases. 
Previously, Takahashi, et al.12 reported that the incidence 
of neurological events does not differ between vaginal de-
livery and cesarean section. According to their survey, ad-
ministration of epidural anesthesia for painless labor was 
important to vaginal delivery among patients with MMD. 
In our study, two cases underwent vaginal delivery without 
any noticeable event before or after delivery. It is assumed 
that if hypertension, hypotension, or hyperventilation can 
be managed well, delivery method will not substantially af-
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